Crossmark

Outcomes of Distal Rectal Cancer Patients Who Did Not Qualify for Watch-and-Wait: Comparison of Intersphincteric Resection Versus Abdominoperineal Resection

Crossref DOI link: https://doi.org/10.1245/s10434-024-16316-3

Published Online: 2024-10-12

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feferman, Yael

Verheij, Floris S.

Williams, Hannah

Omer, Dana M.

Pappou, Emmanouil P.

Wei, Iris H.

Widmar, Maria

Nash, Garrett M.

Paty, Philip B.

Smith, J. Joshua

Cercek, Andrea

Yaeger, Rona

Segal, Neil H.

Romesser, Paul B.

Crane, Christopher

Saltz, Leonard B.

Weiser, Martin R.

Garcia-Aguilar, Julio
Funding

Funding for this research was provided by:

National Cancer Institute (P30 CA008748)
License Information

Text and Data Mining valid from 2024-10-12

Version of Record valid from 2024-10-12
More Information

Article History

Received: 8 April 2024

Accepted: 17 September 2024

First Online: 12 October 2024

Disclosure

: Julio Garcia-Aguilar owns stock in Intuitive Surgical. J. Joshua Smith received travel support for fellow education from Intuitive Surgical (August 2015); served as a clinical advisor for Guardant Health (March 2019) and as a clinical advisor for Foundation Medicine (April 2022); served as a consultant and speaker for Johnson and Johnson (May 2022); and serves as a clinical advisor and consultant for GlaxoSmithKline (2023–2024). Andrea Cercek declares research funding from GSK and Seagen, and advisory board participation for Roche, Pfizer, GSK Merck, Seagen, Janssen, Illumina, Amgen, and Abbvie. Neil Segal declares consulting/advisory board participation for Agenus, Regeneron, Puretech, Novartis, Numab, and AstraZeneca; research funding from Roche/Genentech, Pfizer, Merck, BMS, AstraZeneca, Puretech, Immunocore, Regeneron, and Agenus; and travel support from AstraZeneca and Regeneron. Paul B. Romesser has received research funding from EMD Serono and XRad Therapeutics; serves as a consultant for Faeth Therapeutics and Natera; and is a member of the advisory boards of the HPV Cancers Alliance and Anal Cancer Foundation. Yael Feferman, Floris S. Verheij, Hannah Williams, Dana M. Omer, Emmanouil P. Pappou, Iris H. Wei, Maria Widmar, Garrett M. Nash, Philip B. Paty, Rona Yaeger, Christopher Crane, Leonard B. Saltz, and Martin R. Weiser have no disclosures to declare that may be relevant to the contents of this study.

Document is current

Any future updates will be listed below